Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gemcitabine and High-dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease

NCT00388349 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00388349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00388349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gemcitabine and High-dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2001
Completion date
September 30, 2010
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin disease, hodgkin's lymphoma, lymphoma